販売および管理費 変化する 日付
AstraZeneca USD 4.07B 1.73B 2026-09
Bayer EUR 3.96B 267M 2026-06
Essilor EUR 5.75B 139M 2026-06
Fresenius EUR 760M 17M 2026-06
Fresenius Medical Care EUR 736.01M 12.99M 2026-06
GlaxoSmithKline GBP 2.16B 39M 2026-09
GRIFOLS EUR 326M 37M 2026-09
Merck EUR 1.57B 49M 2026-06
Novartis USD 3.08B 163M 2026-09
Philips EUR 1.21B 23M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Sanofi EUR 2.31B 325M 2026-09
Smith & Nephew USD 1.45B 29M 2026-06
Sonova Holding CHF 880.2M 300K 2025-06
UCB EUR 1.47B 193M 2025-12